Articles by Daniel Marsh
Applied Digital Stock Dips 10% After Rally, AI Infrastructure Under Scrutiny
Applied Digital (APLD) shares dropped 10% to $38.30 on Monday, retreating from a high of $42.75 as investors locked in gains after a $7.5 billion lease deal.
Ondas Stock Slumps After $199M All-Stock Defense Acquisition
Ondas shares fell 10% after announcing a $199M all-stock acquisition of Omnisys and a share resale filing, raising dilution concerns.
POET Technologies Shares Tumble After $400M Capital Raise
POET Technologies shares dropped 14.2% to $13.70 after a $400M direct investment with MMCAP, issuing 19M shares and warrants at $21. The capital raise follows a $50M Lumilens order and a Q1 net loss.
Plug Power Shares Slide 9.8% as Post-Earnings Rally Fades
Plug Power shares dropped 9.8% to $3.41 on Monday, retreating from a post-earnings rally as concerns over losses and cash burn persist.
Dow Inches Higher, Nasdaq Slips as Bond Yield Retreat Fails to Calm Markets
Stocks were mixed Monday as the Dow edged up but the Nasdaq fell, with bond yields pulling back from recent highs. Dominion Energy jumped on a $66.8B acquisition by NextEra, while Regeneron slid on a trial miss.
BofA Turns Bearish on Salesforce, Flags AI Risk to Growth Model
BofA Securities reinstated Salesforce with an Underperform rating and $160 target, citing AI risks to its growth model. Shares rose despite the bearish note.
Quince Therapeutics Faces Nasdaq Listing Uncertainty Amid Going Concern Warning
Quince Therapeutics stock trades near $1.15 as the company faces Nasdaq compliance issues, a going concern warning, and a failed Phase 3 trial, with a shareholder vote on a reverse stock split scheduled for June 11.
Berkshire Hathaway Takes Stake in Macy's; Stock Rises in Pre-Market
Berkshire Hathaway's new 3.04 million share stake in Macy's, valued at $55 million, lifted shares in pre-market. Q1 results are due June 3, with headwinds from tariffs and weak spending.